Pancreatic Cancer Research

ResearcherUniversity of VeronaActive in the last 2 years

Aleš Tomažič

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1063-8636; OpenAlex author ID A5012672720. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers

Papers 8

  1. Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA Trial. Co-author DOI 10.1001/jamasurg.2025.4054↗
  2. Somatic Mutation Detection in Tumor Tissue and Matched Cell-Free DNA Using PCR-Based Methods in Pancreatic Cancer Patients Undergoing Upfront Resection. Co-author DOI 10.3390/ijms26178518↗
  3. The value of splenectomy during left-sided pancreatectomy for pancreatic ductal adenocarcinoma: predefined subanalysis in the DIPLOMA randomized trial. Co-author DOI 10.1093/bjs/znae236↗
  4. Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Co-author DOI 10.1016/j.lanepe.2023.100673↗
  5. Plasma Extracellular Vesicle Characteristics as Biomarkers of Resectability and Radicality of Surgical Resection in Pancreatic Cancer-A Prospective Cohort Stud… Last author DOI 10.3390/cancers15030605↗
  6. Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA): study protocol for a randomized controlled trial. Co-author DOI 10.1186/s13063-021-05506-z↗
  7. Plasma Extracellular Vesicle Characteristics Correlate with Tumor Differentiation and Predict Overall Survival in Patients with Pancreatic Ductal Adenocarcinom… Co-author DOI 10.3390/jpm11020077↗
  8. Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Sco… Co-author DOI 10.1245/s10434-019-08137-6↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Badovinac · 3 shared papers, 2021–2025 · strength 0.59
  2. Hana Zavrtanik · 3 shared papers, 2021–2025 · strength 0.59
  3. Vita Dolžan · 3 shared papers, 2021–2025 · strength 0.59
  4. Metka Lenassi · 2 shared papers, 2021–2023 · strength 0.34
  5. Matteo De Pastena · 2 shared papers, 2020–2024 · strength 0.22
  6. Tobias Keck · 2 shared papers, 2020–2024 · strength 0.22
  7. Riccardo Casadei · 2 shared papers, 2020–2024 · strength 0.22
  8. Adnan A. Alseidi · 2 shared papers, 2020–2024 · strength 0.22
  9. Safi Dokmak · 2 shared papers, 2020–2024 · strength 0.22
  10. Maarten Korrel · 2 shared papers, 2020–2024 · strength 0.22
  11. Giovanni Butturini · 2 shared papers, 2020–2024 · strength 0.22
  12. Alessandro Zerbi · 2 shared papers, 2020–2024 · strength 0.22
  13. Gianpaolo Balzano · 2 shared papers, 2020–2024 · strength 0.22
  14. Ugo Boggi · 2 shared papers, 2020–2024 · strength 0.22
  15. Marc G. Besselink · 2 shared papers, 2020–2024 · strength 0.22
  16. Jony van Hilst · 2 shared papers, 2020–2024 · strength 0.22
  17. Massimo Falconi · 2 shared papers, 2020–2024 · strength 0.22
  18. Mohammad Abu Hilal · 2 shared papers, 2020–2024 · strength 0.22
  19. Svein Olav Bratlie · 1 shared paper, 2024 · strength 0.13
  20. David A. Kooby · 1 shared paper, 2024 · strength 0.13
  21. Andrea Pietrabissa · 1 shared paper, 2024 · strength 0.13
  22. Bergþór Björnsson · 1 shared paper, 2024 · strength 0.13
  23. Izaak Quintus Molenaar · 1 shared paper, 2024 · strength 0.13
  24. John M. Primrose · 1 shared paper, 2024 · strength 0.13
  25. Giovanni Carlo Ferrari · 1 shared paper, 2024 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.